GovChime
UEI: HTBWRJDPCJ75 • CAGE: 268K0

Candisera Therapeutics, Inc. (TN)

Registration facts

SAM.gov registration as of

SAM.gov registration
Active
Registration expiration date Oct 7, 2027

Registration

Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Sep 18, 2026 (under a year)
Location
Memphis, TN
State of incorporation
Delaware
Purpose of registration
All Awards

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI HTBWRJDPCJ75. GovChime does not check exclusions.

Capabilities

NAICS Codes

As of . Source: SAM.gov Goods & Services NAICS list.

No NAICS codes reported

SBA certifications

No certification in the SBA profile data.

Product and service codes (PSC)

  • AC11NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; BASIC RESEARCH
  • AC13NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT
  • AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
  • AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
  • AC12NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
  • AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
  • 6505DRUGS AND BIOLOGICALS

Contracts

Contracts

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for Candisera Therapeutics, Inc. lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts without a real name are not shown.

Physical Address

3786 Kenwood Ave

Memphis, TN, 38122

USA

Mailing Address

3786 Kenwood Ave

Memphis, TN, 38122

USA

Government Business Contact

Brian M Peters

CEO

3786 Kenwood Ave

Memphis, TN, 38122

USA

Electronic Business Contact

Brian M Peters

CEO

3786 Kenwood Ave

Memphis, TN, 38122

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

Candisera Therapeutics, Inc. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires October 7, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization

Registration Details

Source: SAM.gov

Initial Registration

Sep 24, 2026

Last Update

Oct 20, 2026

Registration Activation

Active — Oct 20, 2026

Fiscal Year End

12/31

Country of Incorporation

USA

Congressional District

09